Headquarters
20 S SARAH ST, SAINT LOUIS, MO 63108-2819, US
SAINT LOUIS, MO, US
From the company
Fimbrion Therapeutics, Inc. is a St. Louis-based company whose mission is to discover, develop, and commercialize antimicrobial-sparing and -enabling drugs for the prevention and treatment of infectious diseases caused by bacteria, including drug-resistant strains. Its initial focus is an orally active drug to prevent and treat urinary tract infections (UTIs), targeting bacterial adhesins rather than bacterial viability.
20 S SARAH ST, SAINT LOUIS, MO 63108-2819, US
Quantities, certifications, and timing.